The Food and Drug Administration (FDA) on Monday launched a new initiative to speed up early-stage clinical trials as part of an effort to reduce development timelines and reverse a growing trend of companies moving overseas, primarily to China. The pilot program, part of a broader initiative across the Department of Health and Human...
The Food and Drug Administration (FDA) on Monday launched a new initiative to speed up early-stage clinical trials as part of an effort to reduce development timelines and reverse a growing trend of companies moving overseas, primarily to China. The pilot program, part of a broader initiative across the Department of Health and Human...
<iframe src="https://statesidedaily.com/embed/cluster/e469e83a874f930dd88b6f37106d2fc7419e14e3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Health officials launch clinical trial reforms to counter China threat"></iframe>
